✦ LIBER ✦

Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours

✍ Scribed by Marc-Eric Halatsch; Ursula Schmidt; Julianne Behnke-Mursch; Andreas Unterberg; Christian Rainer Wirtz

Book ID: 116395024
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 334 KB
Volume: 32
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2006.01.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of epidermal growth factor re

Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast

✍ M�ller, P. ;Mechtersheimer, G. ;Kaufmann, M. ;Moldenhauer, G. ;Momburg, F. ;Matt 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 923 KB

Combination treatment of glioblastoma mu

Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774

✍ Thomas Efferth; Tzutzuy Ramirez; Erich Gebhart; Marc-Eric Halatsch 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Epidermal Growth Factor Receptor and Oth

Epidermal Growth Factor Receptor and Other Molecular Targets in the Treatment of Cancer

✍ Chris H. Takimoto 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 47 KB

Epidermal Growth Factor Receptor Tyrosin

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to the Brain

✍ Jamal-Hanjani, M.; Spicer, J. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 320 KB

Treatment of the T98G glioblastoma cell

Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-α and the epidermal growth factor receptor

✍ Marvin Rubenstein; Roberta Glick; Terry Lichtor; Yelena Mirochnik; Pauline Chou; 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 305 KB

Inhibition of phosphatidylinositol 3-kin

Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells

✍ Manuela Klingler-Hoffmann; Patricia Bukczynska; Tony Tiganis 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 599 KB

## Abstract In __de novo__ glioblastoma multiforme, loss of the tumour suppressor protein PTEN can coincide with the expression of a naturally occurring mutant epidermal growth factor receptor known as ΔEGFR. ΔEGFR signals constitutively via the phosphatidylinositol 3‐kinase (PI3K)/protein kinase A